201 related articles for article (PubMed ID: 18667930)
1. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.
Falcó V; Olmo M; del Saz SV; Guelar A; Santos JR; Gutiérrez M; Colomer D; Deig E; Mateo G; Montero M; Pedrol E; Podzamczer D; Domingo P; Llibre JM
J Acquir Immune Defic Syndr; 2008 Sep; 49(1):26-31. PubMed ID: 18667930
[TBL] [Abstract][Full Text] [Related]
2. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
[TBL] [Abstract][Full Text] [Related]
3. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
[TBL] [Abstract][Full Text] [Related]
4. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
Shah V; Toshniwal H; Shevkani M
J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
[TBL] [Abstract][Full Text] [Related]
5. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era.
Jiang R; Song Z; Liu L; Mei X; Sun J; Qi T; Wang Z; Song W; Tang Y; Yang J; Xu S; Zhao B; Shen Y; Zhang R; Chen J
Front Cell Infect Microbiol; 2023; 13():1208155. PubMed ID: 38029233
[TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
Giancola ML; Rizzi EB; Lorenzini P; Rovighi L; Baldini F; Schininà V; Larussa D; Bibbolino C; Antinori A
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):155-62. PubMed ID: 18240958
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
[TBL] [Abstract][Full Text] [Related]
8. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
9. Unmasking of PML by HAART: unusual clinical features and the role of IRIS.
Sidhu N; McCutchan JA
J Neuroimmunol; 2010 Feb; 219(1-2):100-4. PubMed ID: 19962769
[TBL] [Abstract][Full Text] [Related]
10. Post-cART progressive multifocal leukoencephalopathy era in a Brazilian center.
Lima MA; Silva MTT; Afonso LA; Vaz BJP
J Neurol Sci; 2017 Oct; 381():321-324. PubMed ID: 28991708
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.
Antinori A; Ammassari A; Giancola ML; Cingolani A; Grisetti S; Murri R; Alba L; Ciancio B; Soldani F; Larussa D; Ippolito G; De Luca A
J Neurovirol; 2001 Aug; 7(4):323-8. PubMed ID: 11517411
[TBL] [Abstract][Full Text] [Related]
12. Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital.
Riveiro-Barciela M; Falcó V; Burgos J; Curran A; Van den Eynde E; Navarro J; Villar del Saz S; Ocaña I; Ribera E; Crespo M; Pahissa A
HIV Med; 2013 Jan; 14(1):21-30. PubMed ID: 22726389
[TBL] [Abstract][Full Text] [Related]
13. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.
Cinque P; Pierotti C; Viganò MG; Bestetti A; Fausti C; Bertelli D; Lazzarin A
J Neurovirol; 2001 Aug; 7(4):358-63. PubMed ID: 11517417
[TBL] [Abstract][Full Text] [Related]
14. [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy].
Imamura E; Yamashita H; Fukuhara T; Sawa H; Nagashima K; Kuwabara M; Tokinobu H
Rinsho Shinkeigaku; 2007 Oct; 47(10):650-6. PubMed ID: 18095498
[TBL] [Abstract][Full Text] [Related]
15. Slowly progressive fatal PML-IRIS following antiretroviral initiation at CD4+ nadir of 350 cells/mm
Sandhu MR; Rutledge R; Grant M; Mahajan A; Spudich S
Int J STD AIDS; 2019 Jul; 30(8):810-813. PubMed ID: 31046614
[No Abstract] [Full Text] [Related]
16. Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score?
Fanjul F; Riveiro-Barciela M; Gonzalez J; Delgado E; Murillas J; Payeras Cifré A; Falcó V; Riera M
HIV Med; 2013 May; 14(5):321-5. PubMed ID: 23217049
[TBL] [Abstract][Full Text] [Related]
17. Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era.
Summers NA; Kelley CF; Armstrong W; Marconi VC; Nguyen ML
AIDS Res Hum Retroviruses; 2019 Jun; 35(6):544-552. PubMed ID: 30834775
[TBL] [Abstract][Full Text] [Related]
18. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Paglia MG; Govoni A; Murri R; Testa L; Monforte AD; Antinori A
AIDS; 2000 Sep; 14(14):F117-21. PubMed ID: 11061646
[TBL] [Abstract][Full Text] [Related]
19. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
[TBL] [Abstract][Full Text] [Related]
20. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
Hall CD; Dafni U; Simpson D; Clifford D; Wetherill PE; Cohen B; McArthur J; Hollander H; Yainnoutsos C; Major E; Millar L; Timpone J
N Engl J Med; 1998 May; 338(19):1345-51. PubMed ID: 9571254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
